This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07949/identifier/pdb/
dctermshttp://purl.org/dc/terms/
n5http://linked.opendata.cz/resource/drugbank/drug/DB07949/identifier/pubchem-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07949/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07949/identifier/drugbank/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07949/identifier/chemspider/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07949
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n10:DB07949 n11:DB07949
dcterms:title
({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID
adms:identifier
n4:10015460 n5:11840955 n8:99444420 n13:DB07949 n14:IAA
n6:IUPAC-Name
n7:271B4F22-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B4F28-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B4F27-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B4F24-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B4F25-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B4F26-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B4F20-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B4F1E-363D-11E5-9242-09173F13E4C5 n7:271B4F21-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B4F1F-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B4F2E-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B4F2F-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B4F29-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B4F2A-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B4F2C-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B4F2B-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B4F2D-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B4F34-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B4F36-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B4F37-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B4F33-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B4F32-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B4F35-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B4F23-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B4F30-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B4F31-363D-11E5-9242-09173F13E4C5